Zobrazeno 1 - 10
of 215
pro vyhledávání: '"Stewart Pb"'
Autor:
Chavez Ortiz JL; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Oak Ridge Institute for Science and Education, Atlanta, Georgia, USA., Griffin I; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Kazakova SV; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Stewart PB; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Chenega Corporation, Atlanta, Georgia, USA., Kracalik I; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Basavaraju SV; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Publikováno v:
Transfusion [Transfusion] 2024 Apr; Vol. 64 (4), pp. 627-637. Date of Electronic Publication: 2024 Mar 12.
Publikováno v:
Journal of Medicinal Chemistry. 20:205-209
The synthesis and properties of the title compounds 1 are described. Many of these compounds are potent inhibitors of the passive cutaneous anaphylaxis reaction of rats against egg albumin challenge. Structural variations include substitutions in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6308be4e47e5d9b9401b8f14129cd559
https://doi.org/10.1021/jm00212a004
https://doi.org/10.1021/jm00212a004
Autor:
Stewart Pb, El-Azab J
Publikováno v:
International Archives of Allergy and Immunology. 55:343-349
DSCG and PRD-92-Ea showed tachyphylaxis in the rat PCA test when a large intravenous dose (40 mg/kg of DSCG and 20 mg/kg of PRD-92-Ea) was given 30 min before administering intravenously the expected effective doses at the time of antigen challenge.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b793d8c506a8090c1b2c9c5bc67ed8ee
https://doi.org/10.1159/000231945
https://doi.org/10.1159/000231945
Autor:
Stewart PB; Impact Education Services, College Station, Texas 77845, USA., Deck ML
Publikováno v:
Critical care nursing clinics of North America [Crit Care Nurs Clin North Am] 2001 Mar; Vol. 13 (1), pp. 137-46.
Autor:
Stewart Pb, El-Azab J
Publikováno v:
International archives of allergy and applied immunology. 55(1-6)
PRD-92-Ea [5,5-Dimethyl-11-oxo-5H, HH-(2) benzopyrano (4,3-g) (1) benzopyran-9-carboxylic acid ethanolamine], was an active antiallergic compound in rat and monkey experimental models of immediate hypersensitivity. It inhibited, in a dose-dependent m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9e7734b5e7d0981591f5ad759573633
https://pubmed.ncbi.nlm.nih.gov/73514
https://pubmed.ncbi.nlm.nih.gov/73514
Autor:
Crossin JA; Surgery Education Program, Methodist Hospital of Indiana, Indianapolis, USA., Johnson AC, Stewart PB, Turner WW Jr
Publikováno v:
The American surgeon [Am Surg] 1998 Jul; Vol. 64 (7), pp. 666-8; discussion 669.
Autor:
Stewart PB
Publikováno v:
Nursing staff development insider [Nurs Staff Dev Insid] 1993 Nov-Dec; Vol. 2 (6), pp. 2, 4.
Autor:
Stewart PB
Publikováno v:
Nursing staff development insider [Nurs Staff Dev Insid] 1993 Sep-Oct; Vol. 2 (5), pp. 1, 3.
Autor:
El-Azab J, Stewart PB
Publikováno v:
International archives of allergy and applied immunology [Int Arch Allergy Appl Immunol] 1977; Vol. 55 (1-6), pp. 350-61.
Autor:
Stewart PB; Ambulatory and Critical Care Nursing Service, St. Luke's Episcopal Hospital, Houston, TX.
Publikováno v:
The American journal of nursing [Am J Nurs] 1989 Nov; Vol. 89 (11), pp. 1467-8.